论文部分内容阅读
(1 )干扰素完成了酵母基因工程人α2ａ干扰素和酵母基因工程人α2ｂ干扰素的技术转让 ,和上海万兴生物工程公司共同进行中试开发及新药申报工作 .酵母基因工程人α2ａ干扰素和酵母基因工程人α2ｂ干扰素已取得新药证书及生产文号 ,并分别于 2 0 0 0年 2月及 2 0 0 1年 8月正式
(1) Interferon Completed the technology transfer of yeast genetically engineered human α2a interferon and yeast genetically engineered human α2b interferon and carried out pilot-scale development and new drug application jointly with Shanghai Wanxing Bioengineering Co. Yeast genetic engineering human α2a interferon And yeast gene engineering human α2b interferon has obtained a new drug certificate and production number, and in February 2000 and August 2001 formally